Precision Radiation Therapy for Metastatic Spinal Cord Compression: Final Results of the PRE-MODE Trial.
Autor: | Rades D; Department of Radiation Oncology, University of Lübeck, Luebeck, Germany. Electronic address: Rades.Dirk@gmx.net., Cacicedo J; Department of Radiation Oncology, Cruces University Hospital, Barakaldo, Vizcaya, Spain., Conde-Moreno AJ; Department of Radiation Oncology, Consorcio Hospital Provincial de Castellon, Castellon, Spain; Department of Radiation Oncology, University and Polytechnic Hospital La Fe, Valencia, Spain., Segedin B; Department of Radiotherapy, Institute of Oncology Ljubljana, Ljubljana, Slovenia., But-Hadzic J; Department of Radiotherapy, Institute of Oncology Ljubljana, Ljubljana, Slovenia., Groselj B; Department of Radiotherapy, Institute of Oncology Ljubljana, Ljubljana, Slovenia., Kevlishvili G; Radiation Oncology Department, University Clinic Tbilisi, Tbilisi, Georgia., Lomidze D; Radiation Oncology Department, University Clinic Tbilisi, Tbilisi, Georgia., Ciervide-Jurio R; Department of Radiation Oncology, University Hospital HM Sanchinarro, Madrid, Spain., Rubio C; Department of Radiation Oncology, University Hospital HM Sanchinarro, Madrid, Spain., Perez-Romasanta LA; Department of Radiation Oncology, University Hospital Salamanca, Salamanca, Spain., Alvarez-Gracia A; Department of Radiation Oncology, ICO - University Hospital Germans Trias i Pujol, Badalona, Spain., Olbrich D; Centre for Clinical Trials Lübeck, Luebeck, Germany., Doemer C; Department of Radiation Oncology, University of Lübeck, Luebeck, Germany., Schild SE; Department of Radiation Oncology, Mayo Clinic, Scottsdale, Arizona., Hollaender NH; Department of Oncology and Palliative Units, Zealand University Hospital, Naestved, Denmark. |
---|---|
Jazyk: | angličtina |
Zdroj: | International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2020 Mar 15; Vol. 106 (4), pp. 780-789. Date of Electronic Publication: 2019 Dec 05. |
DOI: | 10.1016/j.ijrobp.2019.11.401 |
Abstrakt: | Objective: To investigate precision radiation therapy for metastatic spinal cord compression and compare it to conventional radiation therapy. Methods and Materials: In a multicenter phase 2 study, 40 patients received 5 Gy × 5 fractions of precision radiation therapy (38 volume modulated arc therapy, 2 intensity modulated radiation therapy) for metastatic spinal cord compression and were evaluated for local progression-free survival (LPFS), motor function, ambulatory status, sensory function, sphincter dysfunction, pain, distress, overall survival (OS), and toxicity. Maximum spinal cord dose was 101.5% (myelopathy risk, <0.03%) of the prescription dose. Patients were compared with a historical control group conventionally irradiated with 4 Gy × 5 fractions (propensity score analysis). The equivalent dose in 2 Gy-fractions of 5 Gy × 5 fractions is similar to 3 Gy × 10 fractions, which results in better LPFS than 4 Gy × 5 fractions. It was assumed that 5 Gy × 5 fractions is also superior to 4 Gy × 5 fractions for LPFS. (ClinicalTrials.gov-identifier: NCT03070431) RESULTS: Six-month rates of LPFS and OS were 95.0% and 42.6%, respectively. Improvement of motor function occurred in 24 patients (60%). Thirty-three patients (82.5%) were ambulatory after radiation therapy. Eight of 16 patients (50.0%) with sensory deficits improved. Pain and distress relief were reported by 61.9% and 54.2% of patients 1 month after radiation therapy. Grade 3 toxicities occurred in 1 patient and grade 2 toxicities in another 3 patients. Of the control group, 664 patients qualified for the propensity score analysis; 5 Gy × 5 fractions was significantly superior to 4 Gy × 5 fractions with regard to LPFS (P = .026) but not motor function (P = .51) or OS (P = .82). Conclusions: Precision radiation therapy with 5 Gy × 5 fractions was well tolerated and effective and appeared superior to 4 Gy × 5 fractions in terms of LPFS. The retrospective nature of the historic control group, which might have led to a hidden selection bias, needs to be considered when interpreting the results. (Copyright © 2019 Elsevier Inc. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |